Briggs Morrison, Crossbow Therapeutics CEO
Briggs Morrison helms new MPM oncology startup with Pfizer Ventures, Polaris partners on board
Briggs Morrison has a new oncology biotech in the works.
Syndax Pharmaceuticals said on March 30 that Morrison was departing as head of R …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
